These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14739827)

  • 1. Obligate acceleromyography and pharmacologic reversal of all neuromuscular blocking agents: really, and where is the clinical outcome?
    Kempen PM
    Anesthesiology; 2004 Feb; 100(2):453; author reply 454-5. PubMed ID: 14739827
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-based practice and neuromuscular monitoring.
    Craig Pinsker M
    Anesthesiology; 2004 Feb; 100(2):453-4; author reply 454-5. PubMed ID: 14739828
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuromuscular monitoring advancement.
    Rizzi RR
    Anesthesiology; 2004 Feb; 100(2):454; author reply 455. PubMed ID: 14739829
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of the level of paralysis recovery for a rapid antagonism of atracurium neuromuscular blockade with moderate doses of edrophonium.
    Hennart D; d'Hollander A; Plasman C; De Jonckheere M
    Anesthesiology; 1986 Mar; 64(3):384-7. PubMed ID: 3754099
    [No Abstract]   [Full Text] [Related]  

  • 5. Residual paralysis in the recovery period.
    Feldman SA
    Acta Anaesthesiol Belg; 1979; 30 Suppl():193-4. PubMed ID: 547660
    [No Abstract]   [Full Text] [Related]  

  • 6. [Paralysis after long-term administration of neuromuscular blocking agents].
    Sugai N
    Masui; 1992 Jan; 41(1):2-10. PubMed ID: 1545497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged paralysis after treatment with neuromuscular blocking agents.
    Circeo LE; Baquis GD
    Crit Care Med; 1992 Aug; 20(8):1191-2. PubMed ID: 1643902
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of non-depolarizing block by neostigmine.
    Cass NM; Brown WA; Ng KC; Lampard DG
    Anaesth Intensive Care; 1980 Feb; 8(1):16-9. PubMed ID: 7386846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged paralysis after neuromuscular blockade.
    Kurt TL
    J Toxicol Clin Toxicol; 1996; 34(2):253. PubMed ID: 8618266
    [No Abstract]   [Full Text] [Related]  

  • 10. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents.
    Hoyt JW
    New Horiz; 1994 Feb; 2(1):48-55. PubMed ID: 7922429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can residual paralysis be avoided?: A critical appraisal of the use of sugammadex.
    Esteves S
    Eur J Anaesthesiol; 2015 Oct; 32(10):663-5. PubMed ID: 26322661
    [No Abstract]   [Full Text] [Related]  

  • 13. [Residual neuromuscular blockade].
    Fuchs-Buder T; Schmartz D
    Anaesthesist; 2017 Jun; 66(6):465-476. PubMed ID: 28573344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paralyzed by paralysis.
    Murphy MF; Walls RM
    J Emerg Med; 1987; 5(3):243-4. PubMed ID: 3429817
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting).
    Fuchs-Buder T; Mencke T
    Eur J Anaesthesiol Suppl; 2001; 23():53-9. PubMed ID: 11766248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle inexcitability in patients with reversible paralysis following steroids and neuromuscular blockade.
    Rich MM; Teener JW; Raps EC; Bird SJ
    Muscle Nerve; 1998 Sep; 21(9):1231-2. PubMed ID: 9703456
    [No Abstract]   [Full Text] [Related]  

  • 17. [Muscle relaxants in ambulatory anesthesia].
    Takeda J
    Masui; 2008 Jul; 57(7):845-52. PubMed ID: 18649639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misuse of neostigmine for reversal of neuromuscular block.
    Baraka A
    Middle East J Anaesthesiol; 1980 Feb; 5(6):401-6. PubMed ID: 7402092
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of the duration of anesthesia on neuromuscular potency.
    Kopman AF
    Anesthesiology; 2003 May; 98(5):1300; author reply 1300-1. PubMed ID: 12717164
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring and reversal of neuromuscular block.
    Bevan DR
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S10-3. PubMed ID: 10437711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.